Abstract
We reported previously identification of the human MAGE1 gene, which encodes an antigen recognized on human melanoma MZ2-MEL by autologous cytolytic T lymphocytes. In addition to MAGE1, melanoma MZ2-MEL expresses several closely related genes, one of which has been named MAGE2. The complete MAGE2 sequence was obtained and it comprises 3 exons homologous to those of MAGE1 and an additional exon homologous to a region of the first MAGE1 intron. Like the open reading frame of MAGE1, that of MAGE2 is entirely encoded by the last exon. The MAGE1 and MAGE2 sequences of this exon show 82% identity and the putative proteins show 67% identity. The MAGE2 gene is expressed in a higher proportion of melanoma tumors than MAGE1. It is also expressed in many small-cell lung carcinomas and other lung tumors, laryngeal tumors, and sarcomas. No MAGE1 and MAGE2 gene expression was found in a large panel of healthy adult tissues, with the exception of testis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brasseur, F., Marchand, M., Vanwijck, R., Hérin, M., Lethé, B., Chomez, P., and Boon, T. Human gene MAGE1, which codes for a tumor-rejection antigen, is expressed by some breast tumors. Int J Cancer 52: 839–841, 1992
Davis, L. G., Dibner, M. D., and Battey, J. F. Basic Methods in Molecular Biology, Elsevier Science Publishing, New York, 1986
De Vries, J. E. and Spits, H. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells: I. In vitro generation, isolation, and analysis to phenotype and specificity. J Immunol 132: 510–519, 1984
Faisst, S. and Meyer, S. Compilation of vertebrate-encoded transcription factors. Nucleic Acids Res 20 : 3–26, 1992
Frohman, M., Dush, M., and Martin, G. Rapid amplification of full-length cDNA from rare transcripts: amplification using a single gene-specific oligonucleotide primer. Proc Natl Acad Sci USA 85: 8998–9002, 1988
Hérin, M., Lemoine, C., Weynants, P., Vessière, F., Van Pel, A., Knuth, A., Devos, R., and Boon, T. Production of stable cytolytic T-cell clones directed against autologous human melanoma. Int J Cancer 39: 390–396, 1987
Knuth, A., Danowski, B., Oettgen, H., and Old, L. T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin-2-dependent T cell cultures. Proc Natl Acad Sci USA 81: 3511–3515, 1984
Lurquin, C., Van Pel, A., Mariamé, B., De Plaen, E., Szikora, J-P., Janssens, C., Reddehase, M. T., Lejeune, J., and Boon, T. Structure of tum− transplantation antigen P91A: the mutated exon encodes a peptide recognized with Ld by cytolytic T cells. Cell 58: 293–303, 1989
Melton, D. W., McEwan, C., McKie, A., and Reid, A. Expression of the mouse HPRT gene: deletional analysis of the promoter region of an X-chromosome linked housekeeping gene. Cell 44: 319–328, 1986
Mukherji, B. and McAlister, T. Clonal analysis of cytotoxic T cell response against human melanoma. J Exp Med 158: 240–245, 1983
Pfeifer-Ohlsson, S., Goustin, A. S., Rydnert, J., Wahlström, T., Bjersing, L., Stehelin, D., and Ohlsson, R. Spatial and temporal pattern of cellular myc oncogene expression in developing human placenta: implications for embryonic cell proliferation. Cell 38: 585–596, 1984
Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor 1989
Smale, S. T. and Baltimore, D. The “Initiator” as a transcription control element. Cell 57: 103–113, 1989
Traversari, C., van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., Amar-Costesec, A., and Boon, T. A nonapeptide encoded by human gene MAGE1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 176: 1453–1457, 1992a
Traversari, C., van der Bruggen, P., Van den Eynde, B., Hainaut, P., Lemoine, C., Ohta, N., Old, L., and Boon, T. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics 35: 145–152, 1992b
Van den Elsen, P., Georgopoulos, K., Shepley, B-E., Orkin, S., and Terhorst, C. Exon/intron organization of the genes coding for the δ chains of the human and murine T-cell receptor/T3 complex. Proc Natl Acad Sci USA 83: 2944–2948, 1986
Van den Eynde, B., Hainaut, P., Hérin, M., Knuth, A., Lemoine, C., Weynants, P., van der Bruggen, P., Fauchet, R., and Boon, T. Presence on a human melanoma of multiple antigens recognized by autologous CTL. Int J Cancer 44: 634–640, 1989
Van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254: 1643–1647, 1991.
Author information
Authors and Affiliations
Additional information
The nucleotide sequence data reported in this paper have been submitted to the GenBank nucleotide sequence database and have been assigned the accession number L18920.
Rights and permissions
About this article
Cite this article
De Smet, C., Lurquin, C., van der Bruggen, P. et al. Sequence and expression pattern of the human MAGE2 gene. Immunogenetics 39, 121–129 (1994). https://doi.org/10.1007/BF00188615
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00188615